Galderma Group AG (CH:GALD)
:GALD
Want to see CH:GALD full AI Analyst Report?
GALD Stock Chart & Stats
CHF156.85
-CHF8.02(-7.15%)
At close: 4:00 PM EST
CHF156.85
-CHF8.02(-7.15%)
Day’s Range― - ―
52-Week RangeCHF107.40 - CHF173.45
Previous CloseN/A
Volume230.69K
Average Volume (3M)337.59K
Market Cap
CHF40.42B
Enterprise ValueCHF52.08B
Total Cash (Recent Filing)CHF780.00M
Total Debt (Recent Filing)CHF2.75B
Price to Earnings (P/E)81.5
Beta0.76
Next Earnings
Jul 23, 2026Next Dividend Ex-DateN/A
Dividend Yield0.09%
Share Statistics
EPS (TTM)2.69
Shares Outstanding237,897,630
10 Day Avg. Volume210,266
30 Day Avg. Volume337,589
Financial Highlights & Ratios
PEG Ratio0.49
Price to Book (P/B)5.94
Price to Sales (P/S)9.24
P/FCF Ratio46.97
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
CHF190.78Price Target Upside21.63% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
EPS Forecast (FY)4.64
Revenue Forecast (FY)CHF6.31B
Bulls Say, Bears Say
Bulls Say
Profitability Turnaround & High MarginsSustained gross margins near 67–70% combined with a multi-year swing from losses to profits indicate structural margin strength and improved operating leverage. This durable profitability supports reinvestment in products, funds R&D/marketing, and provides a cushion through demand cycles.
Material Free Cash Flow GenerationRobust FCF near $1.0B demonstrates the business converts profits to cash reliably in the latest period, increasing capacity to fund capex, dividends, debt paydown and M&A. Durable cash generation strengthens strategic optionality versus peers with weaker cash profiles.
Marked Deleveraging & Stronger Equity BaseSignificant reduction in leverage and a larger equity base materially improves financial flexibility and lowers solvency risk. With lighter relative debt, the firm is better positioned to invest in growth initiatives, withstand shocks, and pursue strategic transactions without immediate refinancing pressure.
Bears Say
Material Absolute Debt LoadWhile leverage ratios improved, carrying roughly $2.75B of debt is a persistent structural liability: it creates interest expense and refinancing exposure that can constrain capital allocation if revenue growth slows or rates rise, limiting long-term strategic flexibility.
Uneven Revenue MomentumA decline in top-line in the most recent year suggests profits may be driven by mix, cost actions, or non-recurring items rather than consistent organic growth. Durable value creation depends on restoring steady revenue expansion across segments, not solely margin gains.
Historical Cash And Earnings VolatilityThe company's recent improvement follows several years of negative FCF and losses, signaling execution and cyclicality risks. This historical volatility raises questions about consistency of results and whether current cash/earnings strength is fully entrenched across economic cycles.
Galderma Group AG News
GALD FAQ
What was Galderma Group AG’s price range in the past 12 months?
Galderma Group AG lowest stock price was CHF107.40 and its highest was CHF173.45 in the past 12 months.
What is Galderma Group AG’s market cap?
Galderma Group AG’s market cap is CHF40.42B.
When is Galderma Group AG’s upcoming earnings report date?
Galderma Group AG’s upcoming earnings report date is Jul 23, 2026 which is in 37 days.
How were Galderma Group AG’s earnings last quarter?
Galderma Group AG released its earnings results on Mar 05, 2026. The company reported CHF1.602 earnings per share for the quarter, beating the consensus estimate of CHF1.243 by CHF0.358.
Is Galderma Group AG overvalued?
According to Wall Street analysts Galderma Group AG’s price is currently Undervalued.
Does Galderma Group AG pay dividends?
Galderma Group AG pays a Notavailable dividend of CHF0.35 which represents an annual dividend yield of 0.09%. See more information on Galderma Group AG dividends here
What is Galderma Group AG’s EPS estimate?
Galderma Group AG’s EPS estimate is 1.
How many shares outstanding does Galderma Group AG have?
Galderma Group AG has 237,897,630 shares outstanding.
What happened to Galderma Group AG’s price movement after its last earnings report?
Galderma Group AG reported an EPS of CHF1.602 in its last earnings report, beating expectations of CHF1.243. Following the earnings report the stock price went up 6.975%.
Which hedge fund is a major shareholder of Galderma Group AG?
Currently, no hedge funds are holding shares in CH:GALD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Galderma Group AG
Galderma Group AG is a company primarily focused on the cosmetics sector. Its operations are structured around three distinct business segments: Injectable Aesthetics, Dermatological Skincare, and Therapeutic Dermatology.
GALD Stock 12 Month Forecast
Average Price Target
CHF190.78
▲(21.63% Upside)
Technical Analysis
Options Prices
Currently, No data available
---